Podiatrists in Dunnellon, FL Accepting Medicare

2 Podiatrists found. Showing 1 - 2

Dunnellon Podiatry Center P A Podiatrist Medicare: Medicare Enrolled Practice Location: 11786 Cedar Street, Dunnellon Podiatry Center Pa, Dunnellon, FL 34431 Phone: 352-489-6621    Fax: 352-489-6920

Dr. Stacy Lynn Witfill, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 11786 Cedar St, Dunnellon, FL 34431 Phone: 352-489-6621

News Archive

Study undercuts common assumption that immigrant crop workers use SNAP

The federal Supplemental Nutrition Assistance Program - formerly known as "food stamps" - that helps low-income individuals and families purchase food is less likely to be used by farmworkers eligible for the benefit who are immigrants, Hispanic, male, childless or residing in California, new research from UC Davis health economists shows.

Researchers discover three genes that contribute to abnormal growth

By working with Canadians of French ancestry who suffer a rare genetic disease, researchers have discovered how three genes contribute to abnormal growth, making a breakthrough that will improve our understanding of many disorders such as foetal and childhood growth retardation, abnormal development of body parts and cancer.

Women with obstructive sleep apnea may be at increased risk for pregnancy complications

Women with obstructive sleep apnea (OSA) appear to be at greater risk for serious pregnancy complications, longer hospital stays and even admission to the ICU than mothers without the condition, according to a new study of more than 1.5 million pregnancies presented at the ATS 2017 International Conference.

Virtual reality during chemotherapy could help improve breast cancer patients' quality of life

Virtual Reality during chemotherapy has been shown to improve breast cancer patients' quality of life during the most stressful treatments, according to a recent study.

Hawthorn announces licensing deal with University of Pittsburgh for novel monoclonal antibodies for cancer

Hawthorn Pharmaceuticals, Inc. today announced a global licensing deal with the University of Pittsburgh covering a series of novel monoclonal antibodies for cancer. The antibody portfolio targets a variety of cancers through the cell surface chondrotin sulfate proteoglycan 4 (CSPG4), which plays an important role in signaling pathways regulating tumor cell survival, growth, and motility.

Read more Medical News

› Verified 8 days ago